In early 2000, a law firm who had filed a court case claiming that thimerosal was not a necessary vaccine ingredient in civil court was able to bypass the National Vaccine Injury Compensation Program (NVICP). During the discovery process the firm received internal documents from Eli Lilly who first patented Thimerosal in 1929. The information … Continue reading Eli Lilly: The History and Politics Involving Thimerosal Containing Vaccines and Neurological Development Disorders Including Autism